Consort Medical PLC (LSE:CSRT) - Share price


Stock Report

Consort Medical PLC CSRT

Last Price
GBX884.00

Day Change
-6.00|-0.67%

As of 26/06/2019
16:54:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close890.00p
Day Range880.00 - 888.00
Mkt Cap439.30Mil
52-Wk Range700.00 - 1,270.00
Yield %2.34
ISINGB0000946276
Volume76,503
P/E18.63
P/S0.01
P/CF0.13

Share Price

Total Returns 25/06/2019

 Chg (%)  
More ...
Consort Medical PLC-3.26 
FTSE 100 TR GBP2.26
 
Financials
201620172018
More ...
Income Statement
Turnover276.90294.00311.10
Operating Profit17.1027.0030.60
Net Profit16.0022.6016.10
Reported EPS32.3045.7032.70
Balance Sheet
Current Assets110.80122.20132.00
Non Current Assets334.90338.90340.10
Total Assets445.70461.10472.10
Current Liabilities178.80181.80191.90
Total Liabilities---
Total Equity209.10212.10246.30
Cash Flow
Operating Cash Flow43.2044.0032.10
Net Change in Cash-28.403.501.50

Regulatory News

DateAuthor Headline
10/06/2014Emma Wall 3 Attractive UK Mid-Cap Stocks
Despite a five year rally, the FTSE 250 still offers diligent investors the chance of profit. Neptune's Mark Martin reveals his UK mid-cap picks
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
07/12/2018PurchaseMr. Jonathan M Glenn725.7021152.00
07/12/2018PurchasePaul Hayes725.7020145.00
05/12/2018PurchasePaul Hayes761.301,0007,613.00
05/12/2018PurchasePaul Hayes765.601,0007,656.00

Company Profile

Consort Medical PLC is mainly a medical device manufacturer. Its core products include drug delivery devices such as inhaler, auto-injector, nasal and ocular technologies. It also supplies drugs such as active pharmaceutical ingredients.

Sector

Medical Devices

Index

FTSE SmallCap ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Next Event 30/07/2019

Annual Report
Ratios
Comp
More ...
PER (E)26.98
Div Yld (E)2.30
PEG (E)0.00
ROCE7.71
Op Mrgn0.10
EPS Grwth0.01
Dividends
PreviousLatest
More ...
Record Date18/01/1920/09/19
Ex-Div17/01/1919/09/19
Paid15/02/1925/10/19
Amnt7.6013.80
Directors
More ...
Non-Executive DirectorMr. Stephen Paul Crummett
Non-Executive DirectorDr. William Jenkins
Executive Director, Chief Executive OfficerMr. Jonathan M Glenn
Non-Executive DirectorMr. Andrew J Hosty
Executive Director, Chief Financial Officer and Company SecretaryPaul Hayes
Non-Executive DirectorMr. Ian James Nicholson
Non-Executive DirectorMs. Charlotta Ginman
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.